Skip to main content

Table 2 HPV type distribution among HIV-infected and HIV-uninfected women at enrollment

From: A cross-sectional analysis of factors associated with detection of oncogenic human papillomavirus in human immunodeficiency virus-infected and uninfected Kenyan women

HPV TYPES

HIV-INFECTED (N = 115) n (%) or mean (SD, range)

HIV-UNINFECTED (N = 105) n (%) or mean (SD, range)

UNADJUSTED MODEL

ADJUSTED MODELi

OR or IRRl (95% CI)

P-value

aOR or aIRRm (95% CI)

P-value

Any HPV typea

68 (59.1)

37 (35.2)

2.659 (1.540–4.592)

<.001

3.117 (1.460–6.654)

0.003

HR-HPVb

54 (47.0)

29 (27.6)

2.319 (1.321–4.073)

0.003

3.301 (1.483–7.344)

0.003

IARC HR-HPVc

45 (39.1)

25 (23.8)

2.057 (1.146–3.691)

0.016

2.593 (1.147–5.860)

0.022

A9 HPVd

27 (23.5)

16 (15.2)

1.706 (0.860–3.385)

0.126

2.569 (1.023–6.447)

0.045

HPV 16

12 (10.4)

3 (2.9)

3.961 (1.086–14.454)

0.037

9.510 (1.757–51.463)

0.009

Non-HPV 16 A9e

20 (17.4)

13 (12.4)

1.490 (0.700–3.169)

0.301

1.590 (0.583–4.333)

0.365

A7 HPVf

23 (20.0)

9 (8.6)

2.667 (1.172–6.066)

0.019

3.813 (1.284–11.319)

0.016

HPV 18

4 (3.5)

1 (1.0)

3.748 (0.412–34.080)

0.241

4.583 (0.311–67.632)

0.268

HPV 68j

8 (7.0)

0 (0)

10.684 (2.684 - infk)

0.010

10.057 (1.803 - infk)

0.022

Non-HPV 18 A7g

20 (17.4)

8 (7.6)

2.553 (1.072–6.077)

0.034

3.320 (1.037–10.629)

0.043

Any LR-HPVh

37 (32.2)

18 (17.1)

2.293 (1.208–4.352)

0.011

2.122 (0.913–4.932)

0.080

≥2 Types Any HPV

38 (33.0)

11 (10.5)

4.217 (2.021–8.799)

<.001

6.111 (2.265–16.483)

<.001

≥2 Types HR-HPV

23 (20.0)

7 (6.7)

3.500 (1.433–8.544)

0.006

3.705 (1.195–11.488)

0.023

Number of HPV types

1.3 (1.7, 0–7)

0.6 (1.1, 0–8)

2.320 (1.557–3.457)

<.001

2.585 (1.611–4.148)

<.001

Number of HR-HPV types

0.9 (1.2, 0–6)

0.4 (0.7, 0–4)

2.294 (1.463–3.597)

<.001

2.519 (1.476–4.299)

0.001

  1. aHPV 6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 45, 51, 52, 53, 54, 55, 56, 58, 59, 61, 62, 66, 67, 68, 69, 70, 71, 72, 73, 81, 82, 83, 84, CP6108, IS39
  2. bHigh-Risk HPV 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 67, 68, 69, 70, 73, 82, IS39
  3. cHPV 16, 18, 31, 33, 35, 39, 45, 51 52, 56, 58, 59, 66
  4. dHPV 16, 31, 33, 35, 52, 58
  5. eHPV 31, 33, 35, 52, 58
  6. fHPV 18, 39, 45, 59, 68
  7. gHPV 39, 45, 59, 68
  8. hLow-Risk HPV 6, 11, 40, 42, 54, 55, 61, 62, 64, 71, 72, 81, 83, 84, CP6108
  9. iAge, marital status, educational level, home ownership, distance to health care, having medical conditions in the past 12 months, life-time sexual partners, age of first sex, condom use, accumulative years of birth control use, total number of pregnancy, and history of cervical cancer screening, smoking history, history of CT or GC were adjusted as covariates in the logistic regression model or the negative binomial regression model
  10. jExact logistic regression model was conducted for HPV 68 due to low cell sizes
  11. kInfinity
  12. lOdds ratio or Incidence rate ratio; mAdjusted odds ratio or adjusted incidence rate ratio
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us